WASHINGTON – Rep. Doris Matsui (D-Sacramento) released the following statement on girls that can't get enough sex videoAug. 15 after the Biden-Harris Administration announced the results of the first round of Medicare negotiations for ten prescription drugs.
This new authority was given to the Centers for Medicare & Medicaid Services (CMS) under the Inflation Reduction Act (IRA), signed by President Biden in 2022.
“For far too long, Big Pharma has locked lifesaving prescription drugs behind a barrier of absurdly high costs,” said Matsui. “Throughout the Sacramento region and across the nation, Americans are forced into impossible choices when facing these high prices – rationing medications, choosing between groceries or prescriptions, or just going without.
“There’s absolutely no reason Americans should pay prices that are three or four times higher than other countries. That’s why I fought hard to end the ban on Medicare negotiating directly with drug companies through the Inflation Reduction Act.
“Today, we are seeing the life-changing impact of these reforms. By forcing drugmakers to the table, we have secured real price reductions making essential prescription drugs affordable and accessible. These new prices will result in $1.5 billion in direct savings to Medicare beneficiaries’ out-of-pocket costs, and $6 billion in overall savings to the Medicare program.
“This is a historic step forward – but there is more work to do. Now it’s time to build upon this progress for our seniors and expand these savings to even more Americans.”
The drugs covered in the first round of negotiation are:
Eliquis, for preventing strokes and blood clots
Jardiance, for diabetes and heart failure
Xarelto, for preventing strokes and blood clots
Januvia, for diabetes Farxiga, for chronic kidney disease
Entresto, for heart failure
Enbrel, for arthritis and other autoimmune conditions
Imbruvica, for blood cancers
Stelara, for Crohn’s disease
Fias p; Fiasp FlexTouch; Fiasp PenFill; NovoLog; NovoLog FlexPen; NovoLog PenFill insulin products, for diabetes
The negotiated prices for the 10 drugs will go into effect Jan. 1, 2026. In 2023, approximately 8.8 million Medicare beneficiaries took one of the selected drugs. Spending on the ten selected drugs accounted for about 20% of total Part D spending.
Viral TikTok uses data to show the workload of parental leaveIndi One EV 'proof of concept' car debuts at LA Auto ShowHow to set up parental controls on an iPhone5 great laptops for under $1,000How to stop TikTok from suggesting your account from shared linksThousands of Tesla Model X and S vehicles recalled over airbag defectHow to set up an Apple TVUber One subscription gets you discounts on Uber rides, EatsTikTok helps adoptees find a new community to explore joy, family, and belongingPorsche has launched the Taycan GTS and Taycan GTS Sport Turismo Saracens vs. Harlequins 2024 livestream: How to watch Premiership Rugby for free Is 'Sing Sing' streaming? How to watch the A24 drama at home. Mark Lilla’s Comfort Zone Google Pixel Watch 3: $60 off at Amazon Global warming is screwing over polar bears even more than we thought 'Severance' Season 2 finale: Everyone in that cursed Cold Harbor painting Gwyneth Paltrow dislikes intimacy coordinators. What does an intimacy coordinator think? NYT Strands hints, answers for March 23 A captive killer whale mimicked human sounds back to scientists You Are Not a Rebel
0.1559s , 14277.6015625 kb
Copyright © 2025 Powered by 【girls that can't get enough sex video】Matsui Statement on Medicare Negotiated Drug Prices,Global Hot Topic Analysis